W
William C. Olson
Researcher at Regeneron
Publications - 183
Citations - 12479
William C. Olson is an academic researcher from Regeneron. The author has contributed to research in topics: Antibody & Prostate cancer. The author has an hindex of 53, co-authored 175 publications receiving 11009 citations. Previous affiliations of William C. Olson include Cornell University & Massachusetts Institute of Technology.
Papers
More filters
Journal ArticleDOI
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.
Alexandra Trkola,Tatjana Dragic,James Arthos,James M. Binley,William C. Olson,Graham P. Allaway,Cecilia Cheng-Mayer,James E. Robinson,Paul J. Maddon,John P. Moore +9 more
TL;DR: CD4 binding, although not absolutely necessary for the gp120–CCR-5 interaction, greatly increases its efficiency, and interference with HIV-1 binding to one or both of its receptors (CD4 and CCR-5) may be an important mechanism of virus neutralization.
Journal ArticleDOI
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.
Johanna Hansen,Alina Baum,Kristen E. Pascal,Vincenzo Russo,Stephanie Giordano,Elzbieta Wloga,Benjamin O. Fulton,Ying Yan,Katrina Koon,Krunal Patel,Kyung Min Chung,Aynur Hermann,Erica Ullman,Jonathan W. Cruz,Ashique Rafique,Tammy T. Huang,Jeanette L. Fairhurst,Christen Libertiny,Marine Malbec,Wen-Yi Lee,Richard Welsh,Glen Farr,Seth Pennington,Dipali Deshpande,Jemmie Cheng,Anke Watty,Pascal Bouffard,Robert Babb,Natasha Levenkova,Calvin R. Chen,Bojie Zhang,Annabel Romero Hernandez,Kei Saotome,Yi Zhou,Matthew C. Franklin,Sumathi Sivapalasingam,David C. Lye,Stuart Weston,James Logue,Robert Haupt,Matthew B. Frieman,Gang Chen,William C. Olson,Andrew J. Murphy,Neil Stahl,George D. Yancopoulos,Christos A. Kyratsous +46 more
TL;DR: In this article, the authors describe parallel efforts using both humanized mice and convalescent patients to generate antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, which yielded a large collection of fully human antibodies that were characterized for binding, neutralization and three-dimensional structure.
Journal ArticleDOI
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Robert Pejchal,Katie J. Doores,Katie J. Doores,Laura M. Walker,Reza Khayat,Po-Ssu Huang,Sheng-Kai Wang,Robyn L. Stanfield,Jean-Philippe Julien,Alejandra Ramos,Matthew Crispin,Rafael S. Depetris,Umesh Katpally,Andre Marozsan,Albert Cupo,Sebastien M. Maloveste,Yan Liu,Ryan McBride,Yukishige Ito,Rogier W. Sanders,Cassandra Ogohara,James C. Paulson,Ten Feizi,Christopher N. Scanlan,Chi-Huey Wong,John P. Moore,William C. Olson,Andrew B. Ward,Pascal Poignard,Pascal Poignard,William R. Schief,William R. Schief,Dennis R. Burton,Dennis R. Burton,Ian A. Wilson +34 more
TL;DR: The data suggest that the high neutralization potency of PGT 127 and 128 immunoglobulin Gs may be mediated by cross-linking Env trimers on the viral surface.
Journal ArticleDOI
A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure
James M. Binley,Rogier W. Sanders,Brian Clas,Norbert Schuelke,Aditi Master,Yong Guo,Francis Kajumo,Deborah J. Anselma,Paul J. Maddon,William C. Olson,John P. Moore +10 more
TL;DR: A disulfide bond is introduced between the C-terminal region of gp120 and the immunodominant segment of the gp41 ectodomain, producing a properly folded envelope glycoprotein complex which has antigenic properties which resemble those of the virion-associated complex.
Journal ArticleDOI
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
Noura S. Abul-Husn,Xiping Cheng,Alexander H. Li,Yurong Xin,Claudia Schurmann,Panayiotis Stevis,Yashu Liu,Julia Kozlitina,Stefan Stender,G. Craig Wood,Ann Stepanchick,Matthew D. Still,Shane McCarthy,Colm O'Dushlaine,Jonathan S. Packer,Suganthi Balasubramanian,Nehal Gosalia,David Esopi,Sun Y. Kim,Semanti Mukherjee,Alexander E. Lopez,Erin D. Fuller,John Penn,Xin Chu,Jonathan Z. Luo,Uyenlinh L. Mirshahi,David J. Carey,Christopher D. Still,Michael Feldman,Aeron Small,Scott M. Damrauer,Daniel J. Rader,Brian Zambrowicz,William C. Olson,Andrew J. Murphy,Ingrid B. Borecki,Alan R. Shuldiner,Jeffrey G. Reid,John D. Overton,George D. Yancopoulos,Helen H. Hobbs,Jonathan C. Cohen,Omri Gottesman,Tanya M. Teslovich,Aris Baras,Tooraj Mirshahi,Jesper Gromada,Frederick E. Dewey +47 more
TL;DR: A loss‐of‐function variant in HSD17B13 was associated with a reduced risk of chronic liver disease and of progression from steatosis to steatohepatitis.